Trial CTSU-A211102


Testing for Atypia in Random Periareolar Fine Needle Aspiration (Rpfna) Cytology after 12 Months Metformin (1, 1-Dimethylbiguanide Hydrochloride) Chemoprevention versus Placebo Control in Premenopausal Women

Type: Prevention
Phase: Phase III
Status: Not Open (Closed)
Treatments: Other
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Julie Lang, M.D.
Other Trial Staff:  Monica Flores, D.M., Victoria Banerjee, Coordinator, Margarita Carranza, D.M., America Casillas-Lopez, Coordinator, Kristy Watkins, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.